These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 10916078

  • 1. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
    Bokemeyer D, Schmitz U, Kramer HJ.
    Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
    Mugabe BE, Yaghini FA, Song CY, Buharalioglu CK, Waters CM, Malik KU.
    J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
    [Abstract] [Full Text] [Related]

  • 3. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
    Yang CM, Lin MI, Hsieh HL, Sun CC, Ma YH, Hsiao LD.
    J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.
    Touyz RM, Wu XH, He G, Salomon S, Schiffrin EL.
    Hypertension; 2002 Feb; 39(2 Pt 2):479-85. PubMed ID: 11882594
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells.
    Lauzier MC, Pagé EL, Michaud MD, Richard DE.
    Endocrinology; 2007 Aug; 148(8):4023-31. PubMed ID: 17510240
    [Abstract] [Full Text] [Related]

  • 7. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M, Yoshizumi M, Tsuchiya K, Kagami S, Izawa Y, Fujita Y, Ali N, Kanematsu Y, Toida K, Ishimura K, Tamaki T.
    Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II phosphorylation of extracellular signal-regulated kinases in rat anterior pituitary cells.
    Suárez C, Díaz-Torga G, Gonzalez-Iglesias A, Vela J, Mladovan A, Baldi A, Becu-Villalobos D.
    Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E645-53. PubMed ID: 12759218
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
    Meng D, Shi X, Jiang BH, Fang J.
    Free Radic Biol Med; 2007 Jun 01; 42(11):1651-60. PubMed ID: 17462533
    [Abstract] [Full Text] [Related]

  • 10. Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor.
    Iwasaki H, Eguchi S, Ueno H, Marumo F, Hirata Y.
    Endocrinology; 1999 Oct 01; 140(10):4659-68. PubMed ID: 10499523
    [Abstract] [Full Text] [Related]

  • 11. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T.
    J Biol Chem; 1998 Apr 10; 273(15):8890-6. PubMed ID: 9535870
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
    Isenovic ER, Jacobs DB, Kedees MH, Sha Q, Milivojevic N, Kawakami K, Gick G, Sowers JR.
    Endocrinology; 2004 Mar 10; 145(3):1151-60. PubMed ID: 14630723
    [Abstract] [Full Text] [Related]

  • 13. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM, Roztocil E, Davies MG.
    J Vasc Surg; 2005 Apr 10; 41(4):672-81. PubMed ID: 15874933
    [Abstract] [Full Text] [Related]

  • 14. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
    Shah BH, Yesilkaya A, Olivares-Reyes JA, Chen HD, Hunyady L, Catt KJ.
    Mol Endocrinol; 2004 Aug 10; 18(8):2035-48. PubMed ID: 15143154
    [Abstract] [Full Text] [Related]

  • 15. Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells.
    Andresen BT, Linnoila JJ, Jackson EK, Romero GG.
    Hypertension; 2003 Mar 10; 41(3 Pt 2):781-6. PubMed ID: 12623996
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D.
    Li F, Malik KU.
    J Pharmacol Exp Ther; 2005 Mar 10; 312(3):1043-54. PubMed ID: 15525798
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A(2)-mediated release of arachidonic acid.
    Freeman EJ, Sheakley ML, Clements RJ.
    Arch Biochem Biophys; 2010 Jun 01; 498(1):50-6. PubMed ID: 20388488
    [Abstract] [Full Text] [Related]

  • 18. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
    Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, Schiffrin EL.
    Can J Physiol Pharmacol; 2003 Feb 01; 81(2):159-67. PubMed ID: 12710530
    [Abstract] [Full Text] [Related]

  • 19. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
    Min LJ, Mogi M, Li JM, Iwanami J, Iwai M, Horiuchi M.
    Circ Res; 2005 Sep 02; 97(5):434-42. PubMed ID: 16081869
    [Abstract] [Full Text] [Related]

  • 20. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells.
    Yoshimoto T, Fukai N, Sato R, Sugiyama T, Ozawa N, Shichiri M, Hirata Y.
    Endocrinology; 2004 Jul 02; 145(7):3331-7. PubMed ID: 15070851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.